Healthcare disparities, screening, and molecular testing in the changing landscape of non-small cell lung cancer in the United States: a review.
Publication Title
Cancer metastasis reviews
Document Type
Article
Publication Date
5-16-2024
Keywords
Biomarker testing; Healthcare disparities; Lung cancer screening; Non–small cell lung cancer; washington; swedish; swedish cancer; swedish thoracic
Abstract
Inequitable access to care continues to hinder improvements in diagnosis and treatment of lung cancer. This review describes healthcare disparities in the changing landscape of non-small cell lung cancer (NSCLC) in the United States, focusing on racial, ethnic, sex-based, and socioeconomic trends. Furthermore, strategies to address disparities, overcome challenges, and improve patient outcomes are proposed. Barriers exist across lung cancer screening, diagnosis, and treatment regimens, varying by sex, age, race and ethnicity, geography, and socioeconomic status. Incidence and mortality rates of lung cancer are higher among Black men than White men, and incidences in young women are substantially greater than in young men. Disparities may be attributed to geographic differences in screening access, with correlating higher incidence and mortality rates in rural versus urban areas. Lower socioeconomic status is also linked to lower survival rates. Several strategies could help reduce disparities and improve outcomes. Current guidelines could improve screening eligibility by incorporating sex, race, and socioeconomic status variables. Patient and clinician education on screening guidelines and patient-level barriers to care are key, and biomarker testing is critical since ~ 70% of patients with NSCLC have an actionable biomarker. Timely diagnosis, staging, and comprehensive biomarker testing, including cell-free DNA liquid biopsy, may provide valuable treatment guidance for patients with NSCLC. Efforts to improve lung cancer screening and biomarker testing access, decrease bias, and improve education about screening and testing are needed to reduce healthcare disparities in NSCLC.
Clinical Institute
Cancer
Specialty
Oncology
Specialty
Pulmonary Medicine
Specialty
Surgery
Recommended Citation
Kurzrock, Razelle; Chaudhuri, Aadel A; Feller-Kopman, David; Florez, Narjust; Gorden, Jed A; and Wistuba, Ignacio I, "Healthcare disparities, screening, and molecular testing in the changing landscape of non-small cell lung cancer in the United States: a review." (2024). Articles, Abstracts, and Reports. 8866.
https://digitalcommons.providence.org/publications/8866